相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon et al.
CLINICS IN GERIATRIC MEDICINE (2020)
α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment
Md. Razaul Karim et al.
MOLECULAR NEURODEGENERATION (2020)
Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases
Tim Bartels et al.
SCIENCE (2020)
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
Xinhe Wang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Daniel A. Monti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
1H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment
Ana Virel et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer
Ruth E. Musgrove et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genetic risk factors in Parkinson's disease
K. J. Billingsley et al.
CELL AND TISSUE RESEARCH (2018)
The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model
Saebom Lee et al.
HUMAN MOLECULAR GENETICS (2018)
Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
Owen Scudamore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease
Diego Grassi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
Matthew J. Benskey et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice
Saravanan S. Karuppagounder et al.
ANNALS OF NEUROLOGY (2018)
Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System
Vivek Lawana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
Poonam Thakur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death
Lujun Zhou et al.
CELL DEATH & DISEASE (2017)
c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential
Saurav Brahmachari et al.
JOURNAL OF PARKINSONS DISEASE (2017)
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease
Chi Wang Ip et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
Reno C. Reyes et al.
NEUROTHERAPEUTICS (2016)
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
Emma Deas et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration
Saurav Brahmachari et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
Daniel A. Monti et al.
PLOS ONE (2016)
N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins
Arman Rahimmi et al.
BRAIN RESEARCH BULLETIN (2015)
Assessment at the Single-Cell Level Identifies Neuronal Glutathione Depletion As Both a Cause and Effect of Ischemia-Reperfusion Oxidative Stress
Seok Joon Won et al.
JOURNAL OF NEUROSCIENCE (2015)
Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces
Asuka Sasaki et al.
SCIENTIFIC REPORTS (2015)
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Soumitra Ghosh et al.
EBIOMEDICINE (2015)
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
Anne-Laure Mahul-Mellier et al.
HUMAN MOLECULAR GENETICS (2014)
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates
Laura A. Volpicelli-Daley et al.
NATURE PROTOCOLS (2014)
Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
Gordon F. Rushworth et al.
PHARMACOLOGY & THERAPEUTICS (2014)
The chemistry and biological activities of N-acetylcysteine
Yuval Samuni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
α-Synuclein and Mitochondria: Partners in Crime?
Ken Nakamura
NEUROTHERAPEUTICS (2013)
Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System
Sara E. Gombash et al.
PLOS ONE (2013)
A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse
YuHong Fu et al.
BRAIN STRUCTURE & FUNCTION (2012)
NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease
Ana Clara Cristovao et al.
JOURNAL OF NEUROSCIENCE (2012)
N-acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?
Marcos Arturo Martinez-Banaclocha
MEDICAL HYPOTHESES (2012)
N-Acetylcysteine Prevents Loss of Dopaminergic Neurons in the EAAC1-/- Mouse
Ari E. Berman et al.
ANNALS OF NEUROLOGY (2011)
DNA damage response: The emerging role of c-Abl as a regulatory switch?
Emiliano Maiani et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
Syed Z. Imam et al.
JOURNAL OF NEUROSCIENCE (2011)
A rotarod test for evaluation of motor skill learning
Hiromi Shiotsuki et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
Joanne Clark et al.
PLOS ONE (2010)
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Nazzareno Ballatori et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation
Angela M. Brennan et al.
NATURE NEUROSCIENCE (2009)
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells
Audrey Sirvent et al.
BIOLOGY OF THE CELL (2008)
Glutathione and Parkinson's disease: Is this the elephant in the room?
Gail D. Zeevalk et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Mitochondrial complex 1 inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells
Masahiko Watabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: Implications for Parkinson's disease
Shankar J. Chinta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL
E. Weisberg et al.
BRITISH JOURNAL OF CANCER (2006)
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse
K Aoyama et al.
NATURE NEUROSCIENCE (2006)
Regulation of the C-Abl and Bcr-Abl tyrosine kinases
O Hantschel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species
XG Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
